Patients should be our priority number one, and if patients dont have true knowledge of what could happen with GLP-1s, thats a big gap in the responsibility of who is selling these medications to the public and trying to keep them away from the medical decision, he says
Furthermore, semaglutide prevents MASLD/MASH-driven HCC progression in metabolic preclinical models, partly by correcting adipokine imbalances (low adiponectin, high leptin) associated with insulin resistance, which removes a key chronic inflammatory and pro-oncogenic signal linked to the disease (Kojima et al., 2020)
Nonetheless, because of its widespread adoption, inadvertent exposure in early pregnancy is inevitable, and there is hardly any evidence to guide clinical counseling when it happens. How the researchers conducted the study The team examined whether accidental GLP-1 RA use during the periconceptional period was linked to complications such as preterm birth (birth before 37 weeks), preeclampsia, gestational diabetes, giving birth to a child large for gestational age, stillbirth, and problems with the placenta
Muscle weakness or numbness
The Evidence Gap: What Science Actually Says (and Doesnt Say) While BPC-157 and TB-500 are widely hyped online, the scientific support is limited almost entirely to animal studies and cell models
Find ways to relieve stress
